Wearable Evaluation of Ambulatory Readings for Blood Pressure

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorStephen Juraschek

About this trial

The purpose of this project is to compare the performance and validity of novel wearable technologies that measure blood pressure (BP) and physical activity with a Spacelabs Ambulatory Blood Pressure Monitoring (ABPM) device.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18 to 100 years

All neighborhoods in Boston area

Be able to walk with two limbs and have two arms

Willing and able to complete required measurement procedures

Disqualifiers

Failure to receive informed consent

Arm circumference of more than 50cm

Trial design

Design model

Crossover

Treatments tested in this trial

  • ABPMPro

    Device

    This is an upper arm, cuff-based intermittent ambulatory BP device. This device has an internal activity and body position sensor which gathers information about sleep-wake estimation.

  • Spacelabs Ambulatory Blood Pressure Monitoring

    Device

    This is an upper arm cuff-based device with tubing for continuous ambulatory BP monitoring with a unique activity sensor that correlate with patient movement activity with blood pressure changes.

  • Aktiia Blood Pressure

    Device

    This is a wrist cuff-based device which uses an optical sensor (photoplethysmography sensor) to gather data from the arteries under the skin surface. Aktiia has an upper arm cuff device which is used for calibration once every month to provide a baseline blood pressure reading.

  • LiveMetric

    Device

    This is a wrist cuff-based applanation tonometry continuous ambulatory BP device. This device has automatic self-calibration and comes in various sizes.

  • Bpro

    Device

    This is a wrist cuff-based wireless oscillometric, continuous ambulatory BP device. It has applanation tonometry at the wrist with Pulse wave analysis. This device needs calibration with a brachial cuff BP measurement.

Treatment groups

100 Participants
are divided into 3 treatment groups
Group A: Cuff-based ambulatory blood pressure monitor sequenceExperimental treatment 2 interventions
Group B: Left versus right upper limbExperimental treatment 3 interventions
Group C: Wristband sequence (first day versus second day)Experimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Systolic Blood Pressure

Measured from all 5 randomized devices

Time frame
24 - 48 hours

Secondary outcomes

1

Diastolic Blood Pressure

Measured from all 5 randomized devices

Time frame
24 - 48 hours
2

Heart Rate

Measured from all 5 randomized devices

Time frame
24 - 48 hours
3

ActivPaL device (Physical activity monitor)

Physical activity intensity and type of activity will be characterized throughout the 48hr wear period. While the investigators are interested in the impact of devices on activity, the investigators are also interested in the relationship between activities and blood pressure.

Time frame
24 - 48 hours

Other outcomes

1

Systolic blood pressure from the Biobeat device (Chest Patch Blood Pressure device)

This is a continuous ambulatory BP device which is worn as a patch on the chest. This device needs calibration with a brachial cuff BP measurement. This will be typically worn on day 2. This is not a randomized assessment.

Time frame
24 hours

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Stephen Juraschek

Lead sponsor

Beth Israel Deaconess Medical Center

Sponsor institution

National Institutes of Health (NIH)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator